D' Craig Brater, M'D'

1
(No Transcript)
2

• D. Craig Brater, M.D.

3
USPs Mission

• SP promotes the public health and
  benefits practitioners and patients
  by disseminating authoritative standards and
  information developed by its volunteers for
  medicines, other healthcare technologies, and
  related practices used to maintain and improve
  health and promote optimal healthcare delivery.

4
National Product Quality
5
International Product Quality
6
Healthcare Information
7
Patient Safety
8
Making a Difference
9
USPs Vision

• he vision of the United States
  Pharmacopeia is to be a leader in
  advancing the health of the public by creating a
  unique knowledge base on medicines and other
  healthcare technologies. This knowledge base will
  contain state-of-the-art standards to assure the
  quality of these technologies and authoritative
  information to promote their appropriate use. We
  shall make this knowledge base accessible to
  people throughout the world.

10
International Efforts

• USPNF monographs and official Reference
  Standards to facilitate market access to good
  medicines for HIV/AIDS, malaria, tuberculosis
• USP Monographs and Reference Standards to help
  eliminate counterfeit and substandard medicines,
  which increase resistance and worsen prognosis
• Resources from USAID allow USPs Global
  Assistance Initiatives effort to promote drug
  quality and good information in developing
  countries

11
International Efforts

• USPs international compendium will allow
  availability of monographs and Reference
  Standards for HIV/AIDS, malaria, tuberculosis,
  and other dread diseases
• Translations of USPNF into Spanish and other
  major languages
• USP India in the planning stages, per Board of
  Trustees approval

12
Domestic Challenges

• Healthcare is approximately 15 of U.S. GDP
• Recent estimate says 45 million people are
  without healthcare
• 45 of Americans do not receive recommended care
  for common conditions
• Health disparities exist based on race,
  ethnicity, geography, and socioeconomic status
• Estimated 98,000 patients die each year as a
  result of medical errors. Adoption of basic
  research findings is approximately 17 years

13
Domestic Challenges

• Under-investment in information technology
  compared to other industries
• 2000 WHO report says U.S. ranked
• 37th in terms of the overall health system
  performance
• 72nd in terms of level of health
• France ranked number 1

14
USPs Imagined Future
ll therapeutics will meet clearly defined
quality standards that ensure benefit to
practitioners and patients.
We will approach this imagined future with a
sense of urgency and purpose, recognizing the
critical need for good quality, safe, and
effective therapeutic products and authoritative,
unbiased healthcare information. We have promised
we will focus our efforts both domestically and
internationally.
15
Good Health and Good Pharmaceutical Care for All
16
USP Can Make a Difference

• he greater danger for most of us is not
  that our aim is too high and we miss it, but that
  it is too low and we reach it.

Michelangelo